advisorsecurities master

UNCYUnicycive Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
23037
Ticker
UNCY
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-07-13
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
UNCY

Detail

Enriched 2026-08-14 20:47

Market cap
$150,139,835.23
Shares outstanding (class)
27,393,027
Shares outstanding (weighted)
27,855,257
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
22
Location
MOUNTAIN VIEW, CA
Description

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data